|
1
|
Bernstein CN, Blanchard JF, Kliewer E and
Wajda A: Cancer risk in patients with inflammatory bowel disease: A
population-based study. Cancer. 91:854–862. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haberman Y, Karns R, Dexheimer PJ,
Schirmer M, Somekh J, Jurickova I, Braun T, Novak E, Bauman L,
Collins MH, et al: Ulcerative colitis mucosal transcriptomes reveal
mitochondriopathy and personalized mechanisms underlying disease
severity and treatment response. Nat Commun. 10:382019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoving JC: Targeting IL-13 as a
Host-Directed Therapy Against Ulcerative Colitis. Front Cell Infect
Microbiol. 8:3952018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen JH, Andrews JM, Kariyawasam V, Moran
N, Gounder P, Collins G, Walsh AJ, Connor S, Lee TW, Koh CE, et al:
Review article: Acute severe ulcerative colitis-evidence-based
consensus statements. Aliment Pharmacol Ther. 44:127–144. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akao Y, Nakagawa Y and Naoe T: let-7
microRNA functions as a potential growth suppressor in human colon
cancer cells. Biol Pharm Bull. 29:903–906. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kanaan Z, Rai SN, Eichenberger MR, Barnes
C, Dworkin AM, Weller C, Cohen E, Roberts H, Keskey B, Petras RE,
et al: Differential microRNA expression tracks neoplastic
progression in inflammatory bowel disease-associated colorectal
cancer. Hum Mutat. 33:551–560. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hutchings HA, Alrubiay L, Watkins A,
Cheung WY, Seagrove AC and Williams JG: Validation of the Crohn's
and Ulcerative Colitis questionnaire in patients with acute severe
ulcerative colitis. United European Gastroenterol J. 5:571–578.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leake I: IBD: Treatment for acute severe
ulcerative colitis. Nat Rev Gastroenterol Hepatol. 13:4362016.
View Article : Google Scholar
|
|
9
|
Tili E, Michaille JJ, Piurowski V, Rigot B
and Croce CM: MicroRNAs in intestinal barrier function,
inflammatory bowel disease and related cancers-their effects and
therapeutic potentials. Curr Opin Pharmacol. 37:142–150. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alzahrani AM, Hanieh H, Ibrahim HM,
Mohafez O, Shehata T, Bani Ismail M and Alfwuaires M: Enhancing
miR-132 expression by aryl hydrocarbon receptor attenuates
tumorigenesis associated with chronic colitis. Int Immunopharmacol.
52:342–351. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cai M, Chen S and Hu W: MicroRNA-141 Is
Involved in Ulcerative Colitis Pathogenesis via Aiming at CXCL5. J
Interferon Cytokine Res. 37:415–420. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsuzaki J and Suzuki H: Circulating
microRNAs as potential biomarkers to detect transformation of
Barrett's oesophagus to oesophageal adenocarcinoma. BMJ Open
Gastroenterol. 4:e0001602017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matsuzaki J and Ochiya T: Circulating
microRNAs and extracellular vesicles as potential cancer
biomarkers: A systematic review. Int J Clin Oncol. 22:413–420.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamashita S, Yamamoto H, Mimori K, Nishida
N, Takahashi H, Haraguchi N, Tanaka F, Shibata K, Sekimoto M, Ishii
H, et al: MicroRNA-372 is associated with poor prognosis in
colorectal cancer. Oncology. 82:205–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu J, Jin L, Jiang L, Gao L, Zhou J, Hu Y,
Li W, Zhi Q and Zhu X: Serum miR-372 is a diagnostic and prognostic
biomarker in patients with early colorectal cancer. Anticancer
Agents Med Chem. 16:424–431. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Conrad K, Roggenbuck D and Laass MW:
Diagnosis and classification of ulcerative colitis. Autoimmun Rev.
13:463–466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kocsis D, Toth Z, Csontos AA, Miheller P,
Pák P, Herszényi L, Tóth M, Tulassay Z and Juhász M: Prevalence of
inflammatory bowel disease among coeliac disease patients in a
Hungarian coeliac centre. BMC Gastroenterol. 15:1412015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hanafy AS, Monir MH, Abdel Malak H and
Desoky Aiad M: A simple noninvasive score predicts disease activity
and deep remission in ulcerative colitis. Inflamm Intest Dis.
3:16–24. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Asadzadeh-Aghdaee H, Shahrokh S,
Norouzinia M, Hosseini M, Keramatinia A, Jamalan M, Naghibzadeh B,
Sadeghi A, Jahani Sherafat S and Zali MR: Introduction of
inflammatory bowel disease biomarkers panel using protein-protein
interaction (PPI) network analysis. Gastroenterol Hepatol Bed
Bench. 9 (Suppl 1):S8–S13. 2016.PubMed/NCBI
|
|
21
|
Barnes EL and Burakoff R: New biomarkers
for diagnosing inflammatory bowel disease and assessing treatment
outcomes. Inflamm Bowel Dis. 22:2956–2965. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pepys MB and Hirschfield GM: C-reactive
protein: A critical update. J Clin Invest. 111:1805–1812. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fengming Y and Jianbing W: Biomarkers of
inflammatory bowel disease. Dis Markers. 2014:7109152014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Starr AE, Deeke SA, Ning Z, Chiang CK,
Zhang X, Mottawea W, Singleton R, Benchimol EI, Wen M, Mack DR and
Stintzi A: Proteomic analysis of ascending colon biopsies from a
paediatric inflammatory bowel disease inception cohort identifies
protein biomarkers that differentiate Crohn's disease from UC. Gut.
66:1573–1583. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H, Chao K, Ng SC, Bai AH, Yu Q, Yu J,
Li M, Cui Y, Chen M, Hu JF and Zhang S: Pro-inflammatory miR-223
mediates the cross-talk between the IL23 pathway and the intestinal
barrier in inflammatory bowel disease. Genome Biol. 17:582016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pierdomenico M, Cesi V, Cucchiara S,
Vitali R, Prete E, Costanzo M, Aloi M, Oliva S and Stronati L: NOD2
is regulated By Mir-320 in physiological conditions but this
control is altered in inflamed tissues of patients with
inflammatory bowel disease. Inflamm Bowel Dis. 22:315–326. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Krugliak Cleveland N, Rubin DT, Hart J,
Weber CR, Meckel K, Tran AL, Aelvoet AS, Pan I, Gonsalves A,
Gaetano JN, et al: Patients With Ulcerative Colitis and Primary
Sclerosing Cholangitis Frequently Have Subclinical Inflammation in
the Proximal Colon. Clin Gastroenterol Hepatol. 16:68–74. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nairn RC, Savvas R, Hocking G, Kovala M
and Rolland JM: Ulcerative colitis. Animal model: Immunoreactive
inflammation in fetal colon implants in syngeneic adult rats. Am J
Pathol. 96:647–650. 1979.PubMed/NCBI
|
|
29
|
Al Nabhani Z, Montcuquet N, Roy M,
Dussaillant M, Hugot JP and Barreau F: Complementary Roles of Nod2
in hematopoietic and nonhematopoietic cells in preventing gut
barrier dysfunction dependent on MLCK Activity. Inflamm Bowel Dis.
23:1109–1119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang W, Wang X, Zeng B, Liu L, Tardivel
A, Wei H, Han J, MacDonald HR, Tschopp J, Tian Z and Zhou R:
Recognition of gut microbiota by NOD2 is essential for the
homeostasis of intestinal intraepithelial lymphocytes. J Exp Med.
210:2465–2476. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Allen IC, Wilson JE, Schneider M, Lich JD,
Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth
HH, et al: NLRP12 suppresses colon inflammation and tumorigenesis
through the negative regulation of noncanonical NF-κB signaling.
Immunity. 36:742–754. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zaki MH, Vogel P, Malireddi RK,
Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M and
Kanneganti TD: The NOD-like receptor NLRP12 attenuates colon
inflammation and tumorigenesis. Cancer Cell. 20:649–660. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen L, Wilson JE, Koenigsknecht MJ, Chou
WC, Montgomery SA, Truax AD, Brickey WJ, Packey CD, Maharshak N,
Matsushima GK, et al: NLRP12 attenuates colon inflammation by
maintaining colonic microbial diversity and promoting protective
commensal bacterial growth. Nat Immunol. 18:541–551. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lukens JR, Gurung P, Shaw PJ, Barr MJ,
Zaki MH, Brown SA, Vogel P, Chi H and Kanneganti TD: The NLRP12
sensor negatively regulates autoinflammatory disease by modulating
interleukin-4 production in T Cells. Immunity. 42:654–664. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gevers D, Kugathasan S, Denson LA,
Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song
SJ, Yassour M, et al: The treatment-naive microbiome in new-onset
Crohn's disease. Cell Host Microbe. 15:382–392. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sartor RB and Wu GD: Roles for intestinal
bacteria, viruses, and fungi in pathogenesis of inflammatory bowel
diseases and therapeutic approaches. Gastroenterology. 152:327–339,
e324. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Frank DN, St Amand AL, Feldman RA,
Boedeker EC, Harpaz N and Pace NR: Molecular-phylogenetic
characterization of microbial community imbalances in human
inflammatory bowel diseases. Proc Natl Acad Sci USA.
104:13780–13785. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jacob V, Crawford C, Cohen-Mekelburg S,
Viladomiu M, Putzel GG, Schneider Y, Chabouni F, O'Neil S, Bosworth
B, Woo V, et al: Single delivery of high-diversity fecal microbiota
preparation by colonoscopy is safe and effective in increasing
microbial diversity in active ulcerative colitis. Inflamm Bowel
Dis. 23:903–911. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Le Chatelier E, Nielsen T, Qin J, Prifti
E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy
S, et al: Richness of human gut microbiome correlates with
metabolic markers. Nature. 500:541–546. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ridaura VK, Faith JJ, Rey FE, Cheng J,
Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, et
al: Gut microbiota from twins discordant for obesity modulate
metabolism in mice. Science. 341:12412142013. View Article : Google Scholar : PubMed/NCBI
|
